{"protocolSection":{"identificationModule":{"nctId":"NCT04157270","orgStudyIdInfo":{"id":"CLP 14788"},"organization":{"fullName":"Penumbra Inc.","class":"INDUSTRY"},"briefTitle":"LOTUS: Global Acute Stroke Study Utilizing Penumbra System","officialTitle":"LOTUS: Global Acute Stroke Study Utilizing Penumbra System","acronym":"LOTUS"},"statusModule":{"statusVerifiedDate":"2021-06","overallStatus":"TERMINATED","whyStopped":"Business decision to focus on other studies. No safety concern","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-01-12","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-05-10","type":"ACTUAL"},"completionDateStruct":{"date":"2021-05-10","type":"ACTUAL"},"studyFirstSubmitDate":"2019-10-04","studyFirstSubmitQcDate":"2019-11-05","studyFirstPostDateStruct":{"date":"2019-11-08","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-06-22","lastUpdatePostDateStruct":{"date":"2021-06-25","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Penumbra Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUsExport":true},"descriptionModule":{"briefSummary":"The primary objective of this study is to demonstrate safety and effectiveness of the Penumbra System in a population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO)."},"conditionsModule":{"conditions":["Stroke, Ischemic"],"keywords":["Large Vessel Occlusion","LVO","Mechanical Thrombectomy","Penumbra System"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"90 Days","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":23,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Patients with acute ischemic stroke","description":"Patients with acute ischemic stroke secondary to intracranial large vessel occlusion (LVO)","interventionNames":["Device: Penumbra System"]}],"interventions":[{"type":"DEVICE","name":"Penumbra System","description":"Penumbra System","armGroupLabels":["Patients with acute ischemic stroke"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"mTICI Score","description":"Angiographic revascularization of the occluded target vessel at immediate post-procedure as defined by a modified treatment in cerebral infarction (mTICI) score of 2b or higher. mTICI scale ranges from 0 to 3 with higher values representing better outcomes.","timeFrame":"Immediate Post Procedure"},{"measure":"Functional Subject Outcome","description":"Good functional subject outcome at 90 days post-procedure as defined by modified Rankin Scale (mRS) 0-2. mRS scale from from 0 to 6 with higher values representing a worse outcome.","timeFrame":"90 days post"},{"measure":"All-cause mortality at 90 days","description":"All-cause mortality at 90 days","timeFrame":"90 days"}],"secondaryOutcomes":[{"measure":"Safety: Device and procedure related SAE","description":"Incidence of device and procedure related Serious Adverse Events (SAEs)","timeFrame":"Up to 30 days Post Procedure"},{"measure":"Safety: Occurrence of ENT","description":"Occurrence of embolization in previously uninvolved (or new) territories (ENT) as seen on the final control angiogram at the end of procedure","timeFrame":"Immediate Post Procedure"},{"measure":"Safety: Occurrence of Symptomatic intracranial hemorrhage","description":"Occurrence of symptomatic hemorrhages (sICH) at 24 hours","timeFrame":"Up to 24 Hours Post Procedure"},{"measure":"Procedural Time","description":"Time from the arterial puncture to revascularization defined by mTICI 2b or greater","timeFrame":"Immediate Post Procedure"},{"measure":"Stroke Onset to Revascularization","description":"Time from stroke onset to revascularization defined by mTICI 2b or greater","timeFrame":"Immediate Post Procedure"},{"measure":"Complete Revascularization","description":"Complete revascularization, defined as mTICI 2c and 3","timeFrame":"Immediate Post Procedure"},{"measure":"Length of index hospital stay","timeFrame":"Up to 90 days Post Procedure"},{"measure":"Type of Discharge Facility","timeFrame":"Up to 90 days Post Procedure"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient age ≥ 18 and ≤ 85\n* Patient experiencing acute ischemic stroke secondary to intracranial large vessel occlusion who are eligible for mechanical thrombectomy using the Penumbra System\n* Planned frontline treatment with aspiration utilizing Penumbra System\n* Present with symptoms consistent with an acute ischemic stroke within 8 hours of stroke symptom onset\n* National Institute of Health Stroke Scale (NIHSS) ≥ 6\n* Signed informed consent per Institution Review Board/Ethics Committee\n* CT ASPECT score from 6 to 10 (≥ 6) or according to MR DWI ASPECT score from 5 to 10 (≥ 5)\n* Pre-stroke mRS 0-1\n\nExclusion Criteria:\n\n* Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments through 90 days\n* Associated myocardial infarction or severe infection (endocarditis or sepsis)\n* Laboratory evidence of coagulation abnormalities, with an International Normalized Ratio (INR) or \\> 3.0 or platelets count \\< 40 x 10\\^9/L or PTT/APTT \\> 50 sec\n* Uncontrolled hypertension (defined as systolic blood pressure \\> 185 mmHg or diastolic blood pressure \\> 110 mmHg)\n* Baseline glucose \\< 2.7 or \\> 22.2 mmol/L\n* Seizure at the onset of stroke\n* Time of stroke symptom onset unknown\n* Females who are pregnant\n* Known serious sensitivity to radiographic contrast media that cannot be pre-treated\n* Renal failure as defined by serum creatinine \\> 3.0mg/dl (264 µmol/L)\n* Currently participating in an investigational (drug, device, etc.) clinical trial that will confound study endpoints. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible\n* CT/MRI evidence of the following conditions at screening: significant mass effect with midline shift, evidence of intracranial hemorrhage (ICH), aneurysm, or arteriovenous malformation (AVM), or intracranial tumor\n* . Angiographic evidence of preexisting arterial injury, such as carotid dissection, complete cervical carotid occlusion, or vasculitis.\n* Angiographic evidence of occlusions in multiple vascular territories (e.g., bilateral anterior circulation, or anterior circulation/vertebrobasilar system) as confirmed on CTA/MRA, or clinical evidence of bilateral strokes or strokes in multiple territories\n* Excessive arterial tortuosity that would prevent the device from reaching the target vessel","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients experiencing acute ischemic stroke secondary to intracranial large vessel occlusion who are eligible for mechanical thrombectomy using the Penumbra System","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"locations":[{"facility":"RIA","city":"Englewood","state":"Colorado","zip":"80113","country":"United States","geoPoint":{"lat":39.64777,"lon":-104.98776}},{"facility":"Tampa General Hospital/USF","city":"Tampa","state":"Florida","zip":"33606","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Stroke, Ischemic","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}